2 studies found for:    Open Studies | Exclude Unknown | Down syndrome, Alzheimer
Show Display Options
Rank Status Study
1 Recruiting Nicotine Treatment of Cognitive Decline in Down Syndrome
Conditions: Down Syndrome;   Mild Cognitive Impairment
Interventions: Drug: Low Dose Nicotine (7mg);   Drug: Moderate Dose Nicotine (14mg)
2 Recruiting Normalization of dyrk1A and APP Function as an Approach to Improve Cognitive Performance and Decelerate AD Progression in DS Subjects: Epigallocatechin Gallate as Therapeutic Tool
Condition: Down Syndrome (DS)
Intervention: Dietary Supplement: Epigallocatechin-3-gallate (EGCG)

Indicates status has not been verified in more than two years